The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing
about
The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantationIdentification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensThe PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune TargetsSecondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Second class minors: molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules.A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library.A uniform genomic minor histocompatibility antigen typing methodology and database designed to facilitate clinical applications.C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancyConcurrent detection of circulating minor histocompatibility antigen-specific CD8+ T cells in SCT recipients by combinatorial encoding MHC multimersExploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling DonorsMinor H antigens: genes and peptides.T-cell therapy of leukemia.Identification of minor histocompatibility antigens based on the 1000 Genomes ProjectHematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaA divergent Pumilio repeat protein family for pre-rRNA processing and mRNA localization.The immunogenomics of minor histocompatibility antigens.Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maPhenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populationsMinor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.The Use of Kosher Phenotyping for Mapping QTL Affecting Susceptibility to Bovine Respiratory DiseaseA human minor histocompatibility antigen resulting from differential expression due to a gene deletionExploiting beneficial alloreactive T cells.Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantationHapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotypeDissecting graft-versus-leukemia from graft-versus-host-disease using novel strategiesMinor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide.Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis.Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.
P2860
Q24296246-6AA0EB21-8739-40BD-9B6C-F58DFCF2B8B8Q24536117-E7E87FAB-3370-4428-A15E-096673E6B0E0Q24537575-EA52F932-A7FF-4BC8-8400-B50D4A1C15A3Q24673417-4EF14572-E852-4EDD-A185-CD8416D167AAQ24685666-C62E96DB-D621-4977-912F-47C0147E39DCQ26750999-D2FCB4A8-7ADD-482C-8850-DDA78A434AFCQ27653882-7B0752EE-C2F5-41C1-A5C5-037246D66EC3Q30412320-1B51D942-C1FF-47DF-B6F0-490EA880D9BEQ30444065-6DE91880-705E-4372-BB2E-C3CAC99A3B6AQ30884856-17FAF963-BA7F-4B5F-BA0A-8F139E072AC9Q33208694-9A2EEDD5-00E1-41D0-87E7-7A5F9E62E179Q33267303-56040217-546B-4954-8794-3D4193EC0549Q33359498-B8D7C4C3-62E5-40B2-8809-174DA0255C6DQ33709766-7569AD07-AEDD-4D82-9CCF-842C3A54D8BEQ33723635-96BB40BD-F9C1-4D72-BD46-9E3E053C760FQ33952256-B1138790-D5E4-4801-BB13-2A9C495C038FQ34163218-1C4785DD-8476-43CE-87E7-E0FC2CD0ECA4Q34312702-B0860B17-B427-49BF-B6B4-D094D6553A6BQ34314427-A3F2C9AA-4F81-47A0-B4B1-53A49C4B8314Q34553895-1C7549D1-D79C-498D-834A-7DE6A9A09F9BQ34608658-7FED9DF0-8A7F-495C-BB64-6E85A229F48CQ34648976-EE22A2DB-402C-4B16-B302-14FE12C5E03AQ34808353-C6070DCD-8B85-4193-84AF-52E917BFBA6AQ34831821-50353F87-A64B-4DE3-AE5F-2ED74D273C0BQ35030963-B2795FFD-11EF-42E8-A692-46490D75A6C7Q35446852-1FBBD4F9-0684-4A27-B814-F8B45ACCB4E6Q35605318-82B63E64-CD71-4F65-8D82-EFE1CBE7945CQ35865440-4B597929-1D90-444C-A564-5AEA5C3A5743Q35917686-3AE40DAA-DB36-4438-B3A3-5A6D1D70B651Q35989481-24D263CC-98CC-4116-8DEC-36358B188B58Q36370375-68B65E83-5185-49A0-8B5F-214760C027E7Q36498418-746651DA-3155-489F-88FF-7B3864CB9189Q36556944-BFA5C860-09AD-4903-B918-BA90AFBA3FD7Q36791906-12692D88-728C-43D5-AE0D-4E2C550A4C0DQ36819337-CF8DBAF2-4CDB-4EBA-AC86-43AB43E2D1DAQ36830199-86D65408-6D47-4559-BCEF-0A13DC3C1420Q36921230-223C0F8F-2C72-41CA-8884-5AD11F8BDA60Q36979992-94FE105D-B55A-461F-BA6B-0F5335AA2ABFQ36994811-E72944AC-1B19-4CA0-A621-324018E1A76BQ37291529-8E119084-3A38-45FE-8E09-BD15A3D297DC
P2860
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The immunogenicity of a new hu ...... ifferential antigen processing
@ast
The immunogenicity of a new hu ...... ifferential antigen processing
@en
The immunogenicity of a new hu ...... ifferential antigen processing
@nl
type
label
The immunogenicity of a new hu ...... ifferential antigen processing
@ast
The immunogenicity of a new hu ...... ifferential antigen processing
@en
The immunogenicity of a new hu ...... ifferential antigen processing
@nl
prefLabel
The immunogenicity of a new hu ...... ifferential antigen processing
@ast
The immunogenicity of a new hu ...... ifferential antigen processing
@en
The immunogenicity of a new hu ...... ifferential antigen processing
@nl
P2093
P2860
P3181
P356
P1476
The immunogenicity of a new hu ...... ifferential antigen processing
@en
P2093
A G Brickner
A L Zarling
E H Warren
J A Caldwell
J Shabanowitz
L C Eisenlohr
S R Riddell
T N Golovina
V H Engelhard
P2860
P304
P3181
P356
10.1084/JEM.193.2.195
P407
P577
2001-01-01T00:00:00Z